[limited]

Moderna to analyze results of a Covid vaccine trial Force is estimated to have an efficiency of 89-96%.










Moderna, an American pharmaceutical company, announced yesterday that The company has enough data from the final trial to be analyzed for the first stage to assess the efficacy of the developed COVID-19 vaccine, it is currently in the process of preparing the information to be submitted to an independent panel for testing. Safety information exam
An independent research project safety data review committee will analyze the data and will provide further recommendations. Moderna has yet to announce when information about the vaccine's efficacy will be released.


Dr. Anthony Fosy, director of the US National Institute of Allergy and Communicable Diseases. And is the chief physician in สล็อตxo the task force for the control of COVID-19. Of the White House revealed that Moderna may have analyzed the experimental data within a few days. Or more than a week to a few days


Forces doctor expects that Moderna test results Likely to show high performance similar to that of Pfizer. Inc., recently announced This is because both companies' vaccines are very similar. Which is likely to be effective at around 89-96%


Earlier, Pfizer Inc., the largest US pharmaceutical company, and German pharmaceutical company BioNTech announced big progress in trials of the COVID-19 vaccine.


Pfizer and BioNTech announced that their results indicate that Virus vaccine against COVID-19 Which the two companies developed together It is more than 90% effective in antivirus protection for people who have never been infected before. And the company will register the vaccine with the US Food and Drug Administration (FDA) next week. And it is expected that 50 million doses of the vaccine will be produced within this year and 1,300 million doses next year.